MetLife, Inc. Financials

Market Capitalization $60.07 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	17.60
Forward PE	8.95
Price to Sales TTM	$0.84
Price to Book MRQ	$1.95
Enterprise to Revenue	1.93
Enterprise to EBITDA	19.59

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	5.27%
Operating Margin	15.09%
Return on Assets TTM	0.58%
Return on Equity TTM	13.26%

Income Statement

Revenue TTM	$71,343,996,928
Revenue per Share TTM	$99.39
Quarterly Revenue Growth	16.20%
Gross Profit TTM	$18,240,000,000
EBITDA	$7,036,000,256
Net Income to Common TTM	$3,560,999,936
Diluted EPS TTM	$4.93
Quarterly Earnings Growth YoY	174.40%

Balance Sheet

Total Cash MRQ	$29,799,999,488
Total Cash per Share MRQ	$21.52
Total Debt MRQ	$
Total Debt to Equity MRQ	151.46
Current Ratio MRQ	1.59
Book Value per Share MRQ	$44.53

Cash Flow

Operating Cash Flow TTM	$15,169,000,448
Levered Free Cash Flow TTM	$-3,865,999,872

MET Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	692,419,968
Float Shares	1,152,409,158
Avg 10 Volume	3,887,580
Avg 30 Volume	None
Shares Short	6,284,173
Short Ratio	1.81
Short % of Shares	1.09%
% Held by Insiders	16.42%
% Held by Institutions	75.96%

Stock Price Summary

Beta	1.04
Fifty Two Week Low	$64.61
Fifty Two Week High	$89.05
Fifty Two Week Change	18.22%
Day 50 MA	$83.50
Day 200 MA	$77.06

Dividends and Splits

Forward Annual Dividend Rate	$2.18
Forward Annual Dividend Yield	2.53%
Trailing Annual Dividend Rate	$2.18
Trailing Annual Dividend Yield	2.53%
Payout Ratio	43.20%
Dividend Date	2025-03-11
Ex Dividend Date	2025-02-04
Last Split Factor
Last Split Date	2017-08-07